Senn Sean's Form 4 filing
Immix Biopharma, Inc. (IMMX) · filed Jul 18, 2022
- Accession no.
- 0001493152-22-019731
- Filed
- Jul 18, 2022
- Trade date
- Jul 14, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $550. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001493152-22-020155 (Jul 22, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Senn SeanCIK 0001904837 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 14, 2022 | Common Stock | SSaleDisposed | −200 | $2.75 | −$550 | 899,800 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.